Enzo Maresca is unfazed by any pressure surrounding Chelsea as they eye Champions League qualification. Chelsea's fate will ...

Data to be presented at ASCO reflect Boehringer's broad pipeline and growing body of evidence supporting innovative therapies for various cancersPatient-reported outcomes from the Beamion LUNG-1 study ...

Earlier this year, Cullinan said its lead candidate hit the bull's-eye in a midstage lung cancer cancer trial but stayed mum ...

Kapil Mishra, MD, discusses his presentation title "Radiation Retinopathy: Future Strategies" given at the 2025 Retina World ...

Dr Louisa Dlamini from Mabopane makes history as the University of Pretoria’s first black graduate with an MMed in Radiation ...

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

As of March 31, 2025, Aura had cash and cash equivalents and marketable securities totaling $128.0 million. The Company believes its current cash and cash equivalents and marketable securities are ...

Explore trends, growth drivers, and market forecasts for quantitative pathology imaging from 2022 to 2032 in this in-depth ...

However, an oncology dietitian recently revealed that you may want to keep an eye on what you're drinking - at least if you want to reduce the risk of cancer. Nichole, known as oncology.nutrition ...

Mosaic Therapeutics, Ltd ('Mosaic') a targeted oncology therapeutics company dedicated to resolving cancer's complexity with new combination therapies for patients, today announces the in ...

ConcertAI has announced an agreement that will allow Bayer to utilise its Translational360 and AI software-as-a-service (SaaS) solutions to expedite clinical development in precision oncology using ...

We describe experience of such cases at our eyelid and ocular oncology specialist centre. Methods We conducted a retrospective consecutive case review of adult patients with PAM and periocular LM ...